Valuation: Valbiotis

Market Cap 14.24M 15.95M 13.25M 12.05M 22.75M 1.54B 22.85M 159M 62.48M 787M 59.88M 58.57M 2.52B P/E 2026 *
-2.62x
P/E 2027 * -7.53x
Enterprise Value 19.94M 22.33M 18.55M 16.87M 31.86M 2.16B 32M 223M 87.48M 1.1B 83.85M 82.02M 3.54B EV / Sales 2026 *
6.43x
EV / Sales 2027 * 1.96x
Free-Float
97.31%
Yield 2026 *
-
Yield 2027 * -
1 day+1.52%
1 week-5.49%
Current month-12.75%
1 month-25.31%
3 months-23.80%
6 months-41.55%
Current year-13.26%
1 week 0.59
Extreme 0.59
0.66
1 month 0.59
Extreme 0.59
0.79
Current year 0.59
Extreme 0.59
1.3
1 year 0.54
Extreme 0.535
1.3
3 years 0.54
Extreme 0.535
7.5
5 years 0.54
Extreme 0.535
7.5
10 years 0.54
Extreme 0.535
10.65
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 01/03/2024
Chief Tech/Sci/R&D Officer - 01/09/2017
Director TitleAgeSince
Chairman 55 01/03/2017
Director/Board Member - 26/10/2017
Director/Board Member - 18/03/2019
Date Insider Type Main position Quantity % Market Cap. Importance
28/1/22 Others

Founder

42,480 0.4364%
28/1/22 Exercice

Founder

2,095 0.0215%
10/7/21 Exercice

Chief Technology Officer

2,000 0.0206%
Change 5-day change 1-year change 3-year change Capi.($)
+1.52%-5.49%-25.68%-89.55% 15.95M
-2.59%-5.70%+50.69%+86.86% 70.61B
+3.23%-10.67%+6.27%+53.70% 51.01B
+1.56%+1.17%+8.49%+31.81% 48.1B
+0.39%+0.65%+31.14%+28.97% 42.78B
+0.87%-8.17%+293.37%+642.41% 40.67B
+1.24%-1.01%+10.74%+100.64% 40.3B
-2.13%-1.64%+8.63%+46.88% 30.59B
-0.46%-1.28%+42.23%+20.34% 28.16B
+5.32%+0.06%-5.00%-12.78% 24.36B
Average +0.90%-2.94%+42.09%+90.93% 37.66B
Weighted average by Cap. +0.56%-2.94%+51.34%+115.56%

Financials

2026 *2027 *
Net sales 3.1M 3.47M 2.88M 2.62M 4.95M 336M 4.97M 34.71M 13.6M 171M 13.03M 12.75M 550M 12.8M 14.33M 11.91M 10.83M 20.45M 1.39B 20.54M 143M 56.15M 707M 53.82M 52.64M 2.27B
Net income -8.2M -9.18M -7.63M -6.94M -13.1M -889M -13.16M -91.81M -35.97M -453M -34.48M -33.72M -1.45B -2.8M -3.14M -2.6M -2.37M -4.47M -303M -4.49M -31.35M -12.28M -155M -11.77M -11.52M -496M
Net Debt 5.7M 6.38M 5.3M 4.82M 9.11M 618M 9.15M 63.82M 25.01M 315M 23.97M 23.44M 1.01B 10.9M 12.2M 10.14M 9.22M 17.41M 1.18B 17.49M 122M 47.82M 602M 45.83M 44.83M 1.93B
Projected Income Statement - Annual - Valbiotis
Logo Valbiotis
VALBIOTIS is a French laboratory specializing in the creation and distribution of dietary supplements scientifically tested to maintain health at every stage of life. Through an innovative approach combining scientific excellence, plant expertise and a wealth of natural ingredients, VALBIOTIS offers a new generation of dietary supplements to support cardio-metabolic balance and well-being, and address everyday health issues such as sleep, fatigue, mood management, immunity and vitality.
Employees
50
Date Price Change Volume
09/10/26 EUR 0.6020 +1.52% 48,428
08/10/26 EUR 0.5930 -1.17% 149,737
07/10/26 EUR 0.6000 -5.81% 157,590
06/10/26 EUR 0.6370 -0.93% 60,913
05/10/26 EUR 0.6430 +0.94% 41,515
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Ratings Surperformance© - Valbiotis
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.6020EUR
Average target price
1.850EUR
Spread / Average Target
+207.31%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Valbiotis
  1. Stock Market
  2. Stocks
  3. ALVAL Stock